Year: 2014
Type: article
Abstract: Gene activation by the CRISPR/Cas9 system has the potential to enable new approaches to science and medicine, but the technology must be enhanced to robustly control cell behavior. We show that the fusion of two transactivation domains to Cas9 dramatically enhances gene activation to a level that is necessary to reprogram cell phenotype. Targeted activation of the endogenous Myod1 gene locus with this system led to stable and sustained reprogramming of mouse embryonic fibroblasts into skeletal myocytes. The levels of myogenic marker expression obtained by the activation of endogenous Myod1 gene were comparable to that achieved by overexpression of lentivirally delivered MYOD1 transcription factor.
Source: Stem Cell Reports
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,190
Funders: National Science Foundation, American Heart Association, Muscular Dystrophy Association, Flight Attendant Medical Research Institute, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, Division of Chemical, Bioengineering, Environmental, and Transport Systems, National Center for Advancing Translational Sciences
Awards: Circulatory system and integrated muscle tissue for drug and tissue toxicity, CAREER: Photoregulated Gene Expression for Spatiotemporal Control of Morphogenesis, Derivation of Functional Neurons from Human Adult Cells by Nonviral Gene Delivery, Engineering Morphogenetic Factors for Enhanced Genetic Reprogramming, Circulatory system and integrated muscle tissue for drug and tissue toxicity, G4735368124, G5234877896, Oral Therapy for Hemophilia A, Engineering Targeted Epigenetic Modifiers for Precise Control of Gene Regulation, G8595680174, Overcoming Immunosenescence by Nanoparticle-Mediated Activation
OpenAlex ID: W2149142532
